Empowered Funds’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $362K | Buy |
+13,137
| New | +$362K | ﹤0.01% | 1438 |
|
2025
Q1 | – | Sell |
-5,781
| Closed | -$240K | – | 1729 |
|
2024
Q4 | $240K | Buy |
5,781
+582
| +11% | +$24.2K | ﹤0.01% | 1451 |
|
2024
Q3 | $347K | Buy |
5,199
+322
| +7% | +$21.5K | 0.01% | 1211 |
|
2024
Q2 | $579K | Buy |
4,877
+601
| +14% | +$71.4K | 0.01% | 1010 |
|
2024
Q1 | $456K | Buy |
4,276
+904
| +27% | +$96.3K | 0.01% | 1101 |
|
2023
Q4 | $335K | Buy |
3,372
+611
| +22% | +$60.8K | 0.01% | 1084 |
|
2023
Q3 | $285K | Buy |
2,761
+504
| +22% | +$52.1K | 0.01% | 1070 |
|
2023
Q2 | $274K | Buy |
2,257
+822
| +57% | +$99.9K | 0.01% | 991 |
|
2023
Q1 | $220K | Buy |
+1,435
| New | +$220K | 0.01% | 491 |
|
2022
Q3 | – | Sell |
-31,902
| Closed | -$4.56M | – | 360 |
|
2022
Q2 | $4.56M | Buy |
+31,902
| New | +$4.56M | 0.59% | 37 |
|
2021
Q4 | – | Sell |
-4,306
| Closed | -$1.66M | – | 276 |
|
2021
Q3 | $1.66M | Buy |
+4,306
| New | +$1.66M | 0.21% | 105 |
|